A COMPARISON BETWEEN NEXT-GENERATION SEQUENCING AND ASO-QPCR FOR MINIMAL RESIDUAL DISEASE DETECTION IN MULTIPLE MYELOMA

被引：0
|
作者：
Takamatsu, H. [1 ]
Murata, R. [2 ]
Zheng, J. [3 ]
Moorhead, M. [3 ]
Terasaki, Y. [4 ]
Yoshida, T. [5 ]
Faham, M. [3 ]
Nakao, S. [1 ]
机构：
[1] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan
[2] NTT WEST Kanazawa Hosp, Kanazawa, Ishikawa, Japan
[3] Sequenta Inc, San Francisco, CA USA
[4] Toyama City Hosp, Toyama, Japan
[5] Toyama Red Cross Blood Ctr, Toyama, Japan
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P235
引用
收藏
页码：101 / 102
页数：2
相关论文
共 50 条
  • [1] A comparison between next-generation sequencing and ASO-qPCR for minimal residual disease detection in multiple myeloma
    Takamatsu, Hiroyuki
    Murata, Ryoichi
    Zheng, Jianbiao
    Moorhead, Martin
    Terasaki, Yasushi
    Yoshida, Takashi
    Faham, Malek
    Nakao, Shinji
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] A COMPARISON BETWEEN NEXT-GENERATION SEQUENCING AND ASO-QPCR FOR MINIMAL RESIDUAL DISEASE DETECTION IN MULTIPLE MYELOMA: THE CLINICAL VALUE IN ASCT SETTING
    Takamatsu, H.
    Murata, R.
    Ito, S.
    Zheng, J.
    Moorhead, M.
    Terasaki, Y.
    Yoshida, T.
    Faham, M.
    Nakao, S.
    HAEMATOLOGICA, 2014, 99 : 113 - 114
  • [3] A Comparison Between Next-Generation Sequencing and ASO-qPCR For Minimal Residual Disease Detection In Multiple Myeloma: The Clinical Value In ASCT Setting
    Takamatsu, Hiroyuki
    Mura, Ryoichi
    Zheng, Jianbiao
    Moorhead, Martin
    Yasushi, Terasaki
    Takashi, Yoshida
    Faham, Malek
    Nakao, Shinji
    BLOOD, 2013, 122 (21)
  • [4] A comparison of minimal residual disease detection in autografts among ASO-qPCR, droplet digital PCR, and next-generation sequencing in patients with multiple myeloma who underwent autologous stem cell transplantation
    Takamatsu, Hiroyuki
    Wee, Rachel K.
    Zaimoku, Yoshitaka
    Murata, Ryoichi
    Zheng, Jianbiao
    Moorhead, Martin
    Carlton, Victoria E. H.
    Kong, Katherine A.
    Takezako, Naoki
    Ito, Shigeki
    Miyamoto, Toshihiro
    Yokoyama, Kenji
    Matsue, Kosei
    Sato, Tsutomu
    Kurokawa, Toshiro
    Yagi, Hideo
    Terasaki, Yasushi
    Ohata, Kinya
    Matsumoto, Morio
    Yoshida, Takashi
    Faham, Malek
    Nakao, Shinji
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 183 (04) : 664 - 668
  • [5] Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma
    Yao, Qiumei
    Bai, Yinlei
    Orfao, Alberto
    Chim, Chor Sang
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [6] Upgraded Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma
    Yao, Qiumei
    Bai, Yinlei
    Orfao, Alberto
    Kumar, Shaji
    Chim, Chor S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (05): : 679 - 684
  • [7] Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma
    Alejandro Medina
    Noemi Puig
    Juan Flores-Montero
    Cristina Jimenez
    M.-Eugenia Sarasquete
    María Garcia-Alvarez
    Isabel Prieto-Conde
    Carmen Chillon
    Miguel Alcoceba
    Norma C. Gutierrez
    Albert Oriol
    Laura Rosinol
    Joan Bladè
    Mercedes Gironella
    Miguel T. Hernandez
    Veronica Gonzalez-Calle
    Maria-Teresa Cedena
    Bruno Paiva
    Jesus F. San-Miguel
    Juan-Jose Lahuerta
    Maria-Victoria Mateos
    Joaquin Martinez-Lopez
    Alberto Orfao
    Marcos Gonzalez
    Ramon Garcia-Sanz
    Blood Cancer Journal, 10
  • [8] Comparison of Next-Generation Flow Cytometry (NGF) and Next-Generation Sequencing (NGS) in the Assessment of Minimal Residual Disease in Multiple Myeloma
    Wang, Qingqing
    Yao, Li
    Zhu, Mingqing
    Yan, Lingzhi
    Jin, Song
    Shang, Jingjing
    Shi, Xiaolan
    Zhai, Yingying
    Yan, Shuang
    Yao, Weiqin
    You Hongying
    Wu, Depei
    Fu, Chengcheng
    BLOOD, 2022, 140 : 7249 - 7250
  • [9] Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma
    Medina, Alejandro
    Puig, Noemi
    Flores-Montero, Juan
    Jimenez, Cristina
    Sarasquete, M. -Eugenia
    Garcia-Alvarez, Maria
    Prieto-Conde, Isabel
    Chillon, Carmen
    Alcoceba, Miguel
    Gutierrez, Norma C.
    Oriol, Albert
    Rosinol, Laura
    Blade, Joan
    Gironella, Mercedes
    Hernandez, Miguel T.
    Gonzalez-Calle, Veronica
    Cedena, Maria-Teresa
    Paiva, Bruno
    San-Miguel, Jesus F.
    Lahuerta, Juan-Jose
    Mateos, Maria-Victoria
    Martinez-Lopez, Joaquin
    Orfao, Alberto
    Gonzalez, Marcos
    Garcia-Sanz, Ramon
    BLOOD CANCER JOURNAL, 2020, 10 (10)
  • [10] Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma: A Comparison With Real-Time Quantitative PCR
    Yao, Qiumei
    Bai, Yinlei
    Kumar, Shaji
    Au, Elaine
    Orfao, Alberto
    Chim, Chor Sang
    FRONTIERS IN ONCOLOGY, 2021, 10
12345